| Authors: |
Alexander T; Department of Rheumatology and Clinical Immunology, University Medicine Berlin, Berlin, Germany. tobias.alexander@charite.de.; Deutsches RheumaForschungszentrum Berlin - a Leibniz Institute, Berlin, Germany. tobias.alexander@charite.de., Samuelson C; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Daikeler T; Department of Rheumatology, University Hospital Basel, Basel, Switzerland., Henes J; Department for Internal Medicine II (Oncology, Hematology, Rheumatology and Immunology), University Hospital Tuebingen, Tübingen, Germany., Akil M; Department of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Skagerlind L; Department of Hematology, University Hospital Umea, Umea, Sweden., Ehninger G; Medizinische Klinik und Poliklinik I, Technische Universität Dresden, Dresden, Germany., Jantunen E; Department of Internal Medicine, University Hospital Kuopio, Kuopio, Finland.; University of Eastern Finland, Joensuu, Finland.; Institute of Clinical Medicine, Department of Medicine, Kuopio University Hospital, Joensuu, Finland.; Department of Medicine - North Carelia Hospital District, Joensuu, Finland., Badoglio M; EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France, Paris, France., Farge D; Unité de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Hôpital St-Louis, AP-HP, Paris 6, 1 avenue Claude Vellefaux, Paris, France.; Centre de Référence des Maladies auto-immunes systémiques Rares, Filière FAI2R, d'Ile-de-France, MATHEC St-Louis, Paris, France.; EA 3518, Université de Paris, Paris, France.; Department of Internal Medicine, McGill University, Montréal, QC, Canada., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. |